Clinical trial · Interventional
A Supervised Clinic-to-Community Exercise Intervention to Improve Cardiometabolic Health in Survivors of AYA Cancer
A Supervised Clinic-to-Community Exercise Intervention to Improve Cardiometabolic Health in Survivors of Adolescent and Young Adult Cancer: The ACSEND Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI left
Summary
Brief summary (as posted)
The main goal of this clinical trial is to use a novel exercise intervention to improve cardiometabolic and biopsychosocial health outcomes in overweight/obese sedentary survivors of AYA cancers at risk for chronic comorbid conditions. The investigator's hypothesis is that an exercise intervention will improve: cardiometabolic health; body composition; physical fitness and biopsychosocial outcomes when compared to the attention control group.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescent Cancer | — | UNRESOLVED | — |
| Body Composition | — | UNRESOLVED | — |
| Cardiometabolic Dysregulation | — | UNRESOLVED | — |
| Young Adult Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Exercise
- description
- Will receive the exercise intervention
- interventionNames
- Other: Exercise
- type
- NO_INTERVENTION
- label
- Attention Control
- description
- Will not receive the exercise intervention
Primary outcomes (3)
- measure
- Cardiometabolic health - Insulin Resistance
- timeFrame
- change from baseline to 4 months, to 8 months to 1 year
- description
- insulin resistance estimated by HOMA from a fasting blood sample
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: * AYA cancer survivors (18-39) Must be 12 months after treatment No metastatic disease Exclusion Criteria: * Metastatic disease Pregnancy
References
Publications (0)
Data not yet available